| Literature DB >> 32212693 |
Jiali Chen1, Li Tan1, Chengyong Li1,2,3, Chunxia Zhou1,2,3, Pengzhi Hong1,2, Shengli Sun1, Zhong-Ji Qian1,2,3.
Abstract
Microalgae are primary producers with multiple nutrients in aquatic environments and mostly have applications in biological feed and fuel industry. There are few studies assessing the angiotensin-I-converting enzyme (ACE) inhibition potential of Isochrysis zhanjiangensis, other than its antioxidant potential. In this study, we evaluated a peptide from I. zhanjiangensis (PIZ, FEIHCC) and its vascular endothelial factors and mechanism in human umbilical vein endothelial cells (HUVEC). The results reveal that PIZ (IC50 = 61.38 μM) acts against ACE in a non-competitive binding mode. In addition, PIZ inhibits angiotensin II (Ang II)-induced vascular factor secretion and expression by blocking inflammation and apoptosis through nuclear factor κB (NF-κB), nuclear erythroid 2-related factor 2 (Nrf2), mitogen-activated protein kinases (MAPKs), and the serine/threonine kinase (Akt) signal pathways. This study reveals that PIZ has potential to be developed as a therapeutic agent for hypertension and provides a new method of high-value utilization of I. zhanjiangensis.Entities:
Keywords: HUVEC; Isochrysis zhanjiangensis; angiotensin-I-converting enzyme; in silico; peptide
Mesh:
Substances:
Year: 2020 PMID: 32212693 DOI: 10.1021/acs.jafc.0c00925
Source DB: PubMed Journal: J Agric Food Chem ISSN: 0021-8561 Impact factor: 5.279